News

Impact of PDB Structures on Anti-Cancer Drug Approvals

12/02 PDB101 News

A new flyer highlights the Impact of PDB Structures on US FDA Anti-Cancer Drug Approvals (2010-2023) (PDF).

For more, see

  • Impact of structural biology and the Protein Data Bank on US FDA new drug approvals of low molecular weight antineoplastic agents 2019–2023
    (2024) Oncogene 43: 2229-2243 doi: 10.1038/s41388-024-03077-2
  • Impact of the Protein Data Bank on antineoplastic approvals
    (2020) Drug Discovery Today 25:837-850 doi: 10.1016/j.drudis.2020.02.002
<I>Impact of PDB Structures on US FDA Anti-Cancer Drug Approvals (2010-2023)</I>Impact of PDB Structures on US FDA Anti-Cancer Drug Approvals (2010-2023)

News Index